Target Group Inc. (CBDY) stock
Close on Oct 19, 2026Market cap $431.92KP/E –Yield –
Target Group Inc. saw revenue fall 30.7% to $3.50M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $431.92K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $431.92K
- P/E ratio
- –
- Price to sales
- 0.12
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.50M
- Net income
- -$1.82M
- EPS, diluted
- -$0.00
- Book value per share
- -$0.01
- Diluted shares
- 617M
Trading
- Previous close
- $0.00
- Open
- $0.00
- Day's range
- $0.00 – $0.00
- Volume
- 0
- Average volume (20 days)
- 702,361
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | CBDY | S&P 500 | Difference | CBDY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -12.5% | +0.6% | −13.1 pts | ||
| 3 months | -22.2% | +3.4% | −25.6 pts | ||
| Year to date | -53.3% | +13.3% | −66.6 pts | ||
| 1 year | -46.2% | +16.6% | −62.8 pts | ||
| 3 years | -80.0% | +86.4% | −166.4 pts | -41.5% | +23.1% |
| 5 years | -95.8% | +81.9% | −177.6 pts | -46.8% | +12.7% |
| 10 years | -100.0% | +318.9% | −418.9 pts | -67.3% | +15.4% |
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Net income
EPS, diluted
Free cash flow
About Target
Medicinal Chemicals & Botanical Products
Target Group Inc. cultivates, processes, and distributes curated cannabis goods for Canada's medical and adult-use recreational markets. Through subsidiaries such as Canary Rx Inc. and CannaKorp Inc., it provides wholesale and co-packaging services for consumer-packaged cannabis products, integrating research, testing, development, and manufacturing. Its portfolio includes flower and extract vaporizer pods, pre-rolls, infused beverages, infused coffee and tea pods, edibles, and CBD wellness items. The business primarily targets legal wholesale and commercial partners within the cannabis industry, as well as end consumers seeking medical or recreational products.
Company profile, executives and historyTarget stock: common questions
What is Target's stock price?
CBDY closed at $0.00 on Oct 19, 2026, up 0.00% on the day.
What is Target's market cap?
Target was worth $431.92K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is CBDY's P/E ratio?
Target lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.00), so it has no meaningful P/E ratio.
How much revenue does Target make?
Target reported revenue of $3.50M for the twelve months to Jun 30, 2026, down 30.7% from a year earlier.
Does Target pay a dividend?
No. Target has not paid a cash dividend over the last twelve months.
How has CBDY stock performed over the past year?
Including dividends, CBDY returned -46.2% over the past year, against +16.6% for the S&P 500.
Who are Target's competitors?
Companies most similar to Target by business, industry and size include CPMD, HYEX, LEEEF, CWLXF, MEHA.
See a number that looks wrong?